C linical outcomes are improved as a function of earlier tissue-type plasminogen activator (tPA) delivery. 1, 2 Therefore, national guidelines have encouraged rapid evaluation and treatment of patients with acute ischemic stroke. Stroke-specific American Heart Association's "Get With The Guidelines" (GWTG) were created to ensure that evidence-based practices were adopted by hospitals and incorporated into stroke patient care. 3 One GWTG metric is a goal time from patient arrival to treatment with intravenous tPA (door-to-needle time [DNT]) of ≤60 minutes. Despite the known time-dependence of tPA efficacy, only 27% of 25 000 tPA-treated patients within the GTWG database received tPA within 60 minutes of hospital arrival. 4 Lean manufacturing principles were originally pioneered by Taiichi Ohno, father of the Toyota Production System, who aimed to eliminate inefficiencies within automobile production, leaving only the crucial steps that added value to the customer. 5 After 5 decades of use in the manufacturing sector, lean principles have been recently applied to health care, leading to shorter emergency department (ED) wait times and improved procurement of endovascular stents within radiology departments. 6, 7 In early 2011, we assembled a multidisciplinary team to use a common lean tool known as value stream analysis (VSA) to improve DNTs for patients with stroke receiving intravenous tPA. The " current-state analysis" mapped out wasteful operations and those that added value. A " future-state analysis" removed wasteful steps and retained value-added steps. An "action plan" was created to implement the streamlined protocol and provide feedback for continued improvement. The protocol's efficiency and safety metrics were compared before and after implementation.
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Methods

Data Collection
Data were prospectively collected as part of the Cognitive Rehabilitation Research Group Stroke Registry developed at Washington University in 1998. This registry includes patients with stroke admitted to an urban, tertiary care hospital admitting 1500 patients with stroke annually. In the current study, tPA-treated patients with stroke were included with the following clinical information: demographics, medical history, admission National Institutes of Health Stroke Scale, DNT, onset-to-needle time, door-to-CT completion, and door-to-laboratory completion times; discharge location; 90-day modified Rankin Scale; and length of hospital stay. Symptomatic intracerebral hemorrhage (defined as in the National Institute of Neurological Disorders and Stroke tPA trial as intracerebral hemorrhage within 36 hours of symptom onset that correlated with any decline in neurological status) and stroke mimics (defined as a discharge diagnosis other than ischemic stroke) were retrospectively collected from the patients' charts.
Lean Improvement Process and VSA
Beginning in 2006, the hospital's leadership made a commitment to improving the "flow of value" to patients by applying lean principles. Lean performance engineers used several lean tools for process improvement directed at multiple disease processes, one of which was stroke. We present the results of one of several lean strategies, known as VSA, which was used to expedite tPA delivery to patients with acute stroke arriving in the ED. Briefly, a lean engineer, ED and neurology physicians, ED nurses, patient care and radiology technicians, and an ED pharmacist met over the course of 2 days to perform a VSA that involved 4 steps: (1) " current-state analysis": each step of the tPA protocol was identified as a source of lost productivity (ie, waste) or a step that "added value"; (2) " future-state analysis": a "lean" process was formulated to minimize any wasteful operations; (3) an "action plan" was created for rapid implementation of the new protocol; and (4) a "feedback loop" was instituted to continuously identify and eliminate waste over time ( online-only Data Supplement).
Statistical Analysis
The "pre-VSA" epoch (January 1, 2009, to February 28, 2011) was compared with the "post-VSA" epoch (March 1, 2011, to March 1, 2012) with regard to baseline characteristics, protocol metrics, and clinical outcomes. Wilcoxon rank sum and Fisher exact tests measured differences in continuous and binary data, respectively (P<0.05 required for significance). To adjust for imbalances in baseline characteristics, analysis of covariance was performed including all imbalanced variables as covariates and pre-versus post-VSA as a fixed effect on DNTs. Kruskal-Wallis analysis of variance measured differences in DNT over the 4 quarters post-VSA to determine if DNTs were sustained. To assess which baseline or protocol-related variables predicted DNT post-VSA, a linear regression model was created with predictors selected using a forward stepwise procedure (P≤0.20 required for entry; P≤0.05 required to be retained). Predictors considered for the model included door-to-CT time and all baseline characteristics (VSA was not included as a variable because door-to-CT was a major change within the VSA).
Results
Streamlined Protocol Resulting From the VSA
The VSA identified several barriers preventing rapid tPA treatment including: (1) inefficient patient flow, requiring a patient to be routed by emergency medical services to the trauma bay, then to CT, then back to the room; (2) serial processing of multiple tasks and inefficient use of available staff; and (3) delays in laboratory processing in patients . ∞EMS prenotified the ED triage nurse of the patient's arrival so that treating physicians and staff were waiting and ready to evaluate the patient immediately on arrival. The patient could not be preregistered and prior medical records could not be investigated before patient arrival because EMS was not allowed to give patient identifiers by radio due to violation of patient privacy. † Serial tasks were changed to in-parallel. *Head CT moved to first step in the protocol. # Transport from CT to trauma bay might be considered "time-wasteful"; however, 3 reasons prevented using the CT scanner as the location for tPA delivery: (1) given the ED traffic and the demand for CT use, it was necessary to permit its use for other disease categories (such as trauma and others); (2) transport from CT scanner to trauma bay is approximately 30 seconds; and (3) the space and lighting for patient evaluation in the trauma bay are superior to that in the CT scanner room. § Point-of-care INR sent (useful for patients suspected or known to be taking coumadin/warfarin). + Calling the chief resident might be considered "time-wasteful"; however, we ultimately decided that it "added value" by ensuring tPA administration was supervised by experienced physicians, ensuring safe and appropriate tPA delivery. VSA indicates value stream analysis; Neuro MD, neurology medical doctor; Hx, history; NIHSS, National Institutes of Health Stroke Scale; RN, registered nurse; Tech, patient care technician; EMS, emergency medical services; ED, emergency department; tPA, tissue-type plasminogen activator; INR, international normalized ratio.
at Galter Health Sciences Library on December 3, 2012 http://stroke.ahajournals.org/ Downloaded from suspected of being on anticoagulation (Figure) . After the VSA, the streamlined acute stroke protocol addressed these sources of waste at the same time as retaining value-added steps ( Figure) : (1) patients were taken directly to the CT scanner by emergency medical services and then brought to the trauma bay; (2) the ED and neurology residents were assigned distinct and parallel tasks: obtaining the brief history and performing the National Institutes of Health Stroke Scale; a pharmacist and social worker were added to the team to calculate and prepare tPA dose and bring witnesses to the bedside (or by phone) for physicians to determine time of onset; and (3) point-of-care testing for international normalized ratio was implemented.
Patient Characteristics
In the pre-VSA and post-VSA epochs, 132 and 87 patients with ischemic stroke were treated with intravenous tPA, respectively ( Table 1 ). Shorter onset-to-arrival time and arrival "off-hours" (Friday 5 pm to Monday 7 am) have been associated with longer tPA delivery and did not differ between the 2 cohorts. 2, 4, 8 
Protocol Metrics and Clinical Outcomes
Compared with pre-VSA, DNTs and percent of patients treated ≤60 minutes from hospital arrival were improved post-VSA: 60 minutes versus 39 minutes (P<0.0001) and 52% versus 78% (P<0.0001), respectively ( Table 2 ; online-only Data Supplement I through V). After adjustment for imbalanced baseline characteristics, the post-VSA epoch continued to demonstrate significantly lower DNTs (F=32.4, P<0.0001). The frequency distribution shifted to shorter DNTs post-VSA with fewer outliers beyond 100 minutes ( online-only Data Supplement V). DNT improvement also translated to improved onset-to-needle times (P=0.016).
To determine if improved DNTs were sustained throughout the post-VSA year and were not initially reduced due to the novelty of the protocol, the quarterly DNTs were compared and did not differ across the year (P=0.88; online-only Data Supplement I). Moreover, the volume of tPA-treated patients did not appear to adversely affect DNTs because a consistent increase in volume was seen in the post-VSA epoch ( online-only Data Supplement II).
As head CT became the first step in the protocol, door-to-CT times were lower post-VSA (P<0.0001). To determine if routing patients directly to CT contributed to lower DNTs, linear regression for prediction of DNT was performed. To determine if the protocol's efficiency was at the expense of patient safety, clinical outcomes were compared. There were no differences in symptomatic intracerebral hemorrhage, discharge location, 90-day modified Rankin Scale, length of hospital stay, or stroke mimic rate between the 2 epochs.
Discussion
The current study examined the application of "lean" toward quality improvement for expediting tPA administration at an urban, tertiary care hospital. With key 
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members of the stroke team present at a 2-day VSA, several unnecessary and redundant operations were identified and eliminated, leading to lower DNTs with 78% of patients receiving tPA within 1 hour of hospital arrival. Post-VSA, the tPA frequency distribution shifted left on the time axis and became more narrowly distributed with fewer outliers, suggesting not only shorter treatment times, but also less variability in treatment times ( online-only Data Supplement V). This protocol change did not compromise patient safety, because symptomatic intracerebral hemorrhage rates and clinical outcomes did not differ. Our data suggest that removing the additional transportation step (having emergency medical services route patients directly to head CT; Figure) played a large role in the shorter DNT post-VSA ( Table 2 ; linear regression model showing door-to-CT times independently predicted DNTs). Another variable that predicted shorter DNTs was greater onset-toarrival times, which has been found in several large intravenous tPA data sets 2, 4 and indicates an additional educational opportunity to avoid "exhausting" the tPA window when a patient arrives early.
These data come from a single center with small patient numbers, thus limiting our ability to detect potential differences in clinical outcomes. Although the majority of data were prospectively collected, historical controls were used for the comparison cohort, and time-dependent variables unrelated to protocol changes could affect results. The stroke mimic rate did not significantly differ between the 2 cohorts but was 11.5% post-VSA with increased diagnoses due to conversion disorder ( online-only Data Supplement III). Although within the range of other studies reporting stroke mimic rates in tPA-treated patients, [9] [10] [11] expediting tPA may increase the number of stroke mimics treated and warrants continued monitoring of clinical outcomes and rate of symptomatic intracerebral hemorrhage. Of note, both pre-and post-VSA stroke mimic rates may appear falsely low because some physicians may be reluctant to change the discharge diagnosis to stroke mimic if the patient has been treated with tPA.
Conclusion
Lean manufacturing principles were applied to expedite intravenous tPA delivery with dramatic reduction in DNTs and without compromising patient safety. Future studies may determine if this intervention is sustainable across various hospital settings.
Supplemental Expanded Methods:
Lean Improvement Process, Value Stream Analysis, and Streamlined Acute Stroke Protocol
In 2006, the hospital's leadership made a hospital-wide commitment to improving processes by way of lean manufacturing principles, employing lean experts and taking advantage of several lean tools. Lean performance engineers analyzed numerous processes across several departments, of which neurology was one. The VSA directed at our acute stroke protocol represents one aspect of a much larger lean process improvement within the hospital and specifically within the hospital's neuroscience division. Several rapid improvement events (known as Kaizen) and other lean tools such as 5S (sort, straighten, shine, standardize, sustain) were implemented to help develop the standard work for other processes besides tPA delivery, such as: expediting patient discharge, improving flow within the outpatient neurology clinics, and facilitating outside hospital transfers/drip and ships, amongst other projects.
With regard to expediting tPA delivery for patients arriving in the ED, a VSA was performed. Over two days, a multi-disciplinary team met which included: a lean performance management engineer, ED and neurology physicians, ED nurses, patient care and radiology technicians, and an ED pharmacist. The VSA involved four steps outlined below: 1) "Current-State Analysis" -The current acute stroke protocol was mapped out step by step from patient arrival to tPA bolus. A critical review of each step revealed sources of productivity that "added value" or sources of lost productivity, i.e. "waste". Input was obtained from all team members who were directly involved with each step of the process, and team members were asked to build the current tPA protocol, step-by-step. Additional notes were added to the flow-chart to identify steps as "wasteful" or those that "added value". As a brief description of our pre-VSA protocol, since 2004, we have utilized a resident-based stroke protocol placing post-graduate-year-4 ("chief") neurology residents in decision-making roles for tPA administration 1 . The protocol was initiated by the ED triage nurse upon activation of the acute stroke pager. On arrival, the patient was placed in the trauma bay where the junior neurology resident evaluated the patient by obtaining the history, time-of-onset, and NIHSS; the patient care technician obtained the ECG; the nurse place an IV and sent labs; the patient was taken to head CT; and the patient was returned to the room where the neurology resident called the chief resident to discuss the tPA decision.
2) "Future-State Analysis" -The second step of the VSA was to focus on the primary barriers preventing rapid tPA treatment (steps that were wasteful) and eliminate them from the protocol. A root-cause analysis was performed with a goal of identifying the root cause of tPA-treatment delays beyond 30 minutes. Several tPA cases which had DNT's > 30 minutes were discussed. We compared "what actually occurred" to what "should have occurred". Then supporting causes were discussed until one or more rootcauses were identified. In the end, a few root causes for a delay in tPA treatment were identified, from which several potential solutions were identified and Standard Work for this process was defined. Wasteful steps included: 1) inefficient patient flow, requiring a patient to be routed by EMS to the trauma bay, then to CT, then back to the room; such inefficient flow led to redundant procedures whereby a patient was placed on a cardiac monitor, then removed, and then re-attached after imaging; 2) serial processing of multiple tasks and inefficient use of available staff, such as reliance on the neurology resident for obtaining the history, exam, and tracking down witnesses for time-of-onset; and 3) delays in laboratory processing in patients suspected of being on oral anticoagulation. 3) "Action Plan" -Next, a "lean" process was formulated to retain the steps that were crucial to efficient and safe tPA delivery, while excluding those that only caused delay. The action plan described the implementation of a streamlined protocol which addressed the inefficiencies identified in the root-cause analysis: 1) patients were routed directly to the CT scanner by EMS, and then brought to the trauma bay; 2) the ED residents were given a shared responsibility such that the neurology and ED residents divided the tasks of obtaining the brief history and performing the NIHSS. During the daytime hours, (7am-7pm) the ED residents obtain the history while the Neurology residents perform the NIHSS. During the evening hours (7pm-7am) the neurology residents obtain the history while the ED residents performed the NIHSS. In this way the residents would become skilled in acquiring the relevant history/time of onset as well as learning how to perform the NIHSS; the pharmacists and social worker were assigned tasks such as calculating the tPA dose / preparing tPA and bringing witnesses to the bedside (or getting them on the phone) so physicians could quickly determine time of onset, respectively; and 3) point of care (POC) testing for INR was implemented so that patients suspected of being on oral anticoagulation could be tested rapidly. POC INR completion times were not tracked post-VSA (INR results were immediately available at the bedside) and thus could not be compared before and after the protocol change.
While not all inefficiencies could be remedied due to budget or logistical constraints, each was discussed and a solution was provided to the greatest extent possible. The streamlined protocol was initiated on March 1, 2011. Flow-charts of the old and new stroke protocols are shown for comparison of major differences (Figure) . There were no differences between the two protocols with respect to how the residents were trained to obtain the onset time, perform the NIHSS, or manage blood pressure prior to tPA treatment. Moreover, both pre-and post-VSA, the protocol did not require waiting for laboratory results of INR, PTT, or platelet count, unless patients were suspected of having a bleeding abnormality, low platelets, or being on anticoagulation. 4) "Feedback Loop for Continued Improvement"-As an important component of lean methodology, a two-step plan for continued improvement in order to continually identify sources of waste, was created and implemented: (1) when tPA is administered, the case is reviewed by a stroke neurologist and ED attending with stroke fellowship training within 24 hours of tPA administration. For any case that has a DNT outside of the expected range (< 25 minutes or >35 minutes), immediate feedback is requested from the junior ED and neurology residents involved in the tPA case. Details and metrics are reviewed and the potential causes for each delay are identified and addressed through nursing, pharmacy, resident education, attending education, etc. If the DNT is faster than expected, the case is also reviewed in detail to identify ways to continue the process that led to an expedited tPA delivery. The process is modified accordingly and the results of the modification are re-evaluated within monthly quality control meetings. (2) Monthly meetings occur on the 4 th Thursday of each month. All team members (similar representation as in the VSA with neurology / ED residents and attendings, ED nurses, and pharmacists) meet to review every tPA case in detail with particular attention to cases with DNT's > 30 minutes, stroke mimics, and cases of sICH / in-hospital mortality. In this forum we continually monitor standard work. We identify sources of waste and determine how to eliminate them. 
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